STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Clinical trials for STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough head and neck cancers
Disease control OngoingThis study tests whether combining two drugs, pembrolizumab and cabozantinib, can shrink tumors in people with head and neck cancer that has returned or spread and cannot be removed by surgery. The trial includes 36 adults with certain types of head and neck squamous cell carcino…
Matched conditions: STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug cocktail targets tough head and neck tumors
Disease control OngoingThis early-phase study tests a new drug called berzosertib (M6620) alongside standard chemotherapy (cisplatin) and radiation for people with advanced head and neck cancer that has spread to nearby tissues or lymph nodes. The main goal is to find the safest dose and understand sid…
Matched conditions: STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC